[go: up one dir, main page]

GB9921692D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9921692D0
GB9921692D0 GBGB9921692.1A GB9921692A GB9921692D0 GB 9921692 D0 GB9921692 D0 GB 9921692D0 GB 9921692 A GB9921692 A GB 9921692A GB 9921692 D0 GB9921692 D0 GB 9921692D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9921692.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Haleon Alcala SA
Original Assignee
SmithKline Beecham SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham SA filed Critical SmithKline Beecham SA
Priority to GBGB9921692.1A priority Critical patent/GB9921692D0/en
Publication of GB9921692D0 publication Critical patent/GB9921692D0/en
Priority to EP00969255A priority patent/EP1212427A2/en
Priority to CA002383292A priority patent/CA2383292A1/en
Priority to PCT/EP2000/009036 priority patent/WO2001019997A2/en
Priority to AU79041/00A priority patent/AU7904100A/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB9921692.1A 1999-09-14 1999-09-14 Novel compounds Ceased GB9921692D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9921692.1A GB9921692D0 (en) 1999-09-14 1999-09-14 Novel compounds
EP00969255A EP1212427A2 (en) 1999-09-14 2000-09-14 Basb128 polypeptide and polynucleotide fron moraxella catarrhalis
CA002383292A CA2383292A1 (en) 1999-09-14 2000-09-14 Basb128 polypeptide and polynucleotide from moxarella catarrhalis
PCT/EP2000/009036 WO2001019997A2 (en) 1999-09-14 2000-09-14 Basb128 polypeptide and polynucleotide from moxarella catarrhalis
AU79041/00A AU7904100A (en) 1999-09-14 2000-09-14 Novel compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9921692.1A GB9921692D0 (en) 1999-09-14 1999-09-14 Novel compounds

Publications (1)

Publication Number Publication Date
GB9921692D0 true GB9921692D0 (en) 1999-11-17

Family

ID=10860879

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9921692.1A Ceased GB9921692D0 (en) 1999-09-14 1999-09-14 Novel compounds

Country Status (5)

Country Link
EP (1) EP1212427A2 (en)
AU (1) AU7904100A (en)
CA (1) CA2383292A1 (en)
GB (1) GB9921692D0 (en)
WO (1) WO2001019997A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7209524B2 (en) 2001-04-27 2007-04-24 The Directv Group, Inc. Layered modulation for digital signals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712118A (en) * 1993-09-29 1998-01-27 Research Foundation Of State University Of New York Vaccine for branhamella catarrhalis
US6290970B1 (en) * 1995-10-11 2001-09-18 Aventis Pasteur Limited Transferrin receptor protein of Moraxella
AU1824101A (en) * 1999-06-18 2001-01-09 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome

Also Published As

Publication number Publication date
AU7904100A (en) 2001-04-17
EP1212427A2 (en) 2002-06-12
WO2001019997A3 (en) 2001-08-02
CA2383292A1 (en) 2001-03-22
WO2001019997A2 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
EP1140083A4 (en) Novel compounds
GB9902084D0 (en) Novel compounds
GB9902697D0 (en) Novel compounds
EG24063A (en) Novel compounds
GB9901256D0 (en) Novel compounds
GB9902937D0 (en) Novel compounds
GB9902070D0 (en) Novel compounds
GB9902880D0 (en) Novel compounds
GB9901463D0 (en) Novel compounds
GB9902088D0 (en) Novel compounds
GB9901368D0 (en) Novel compounds
GB9901462D0 (en) Novel compounds
GB9901078D0 (en) Novel compounds
GB9901465D0 (en) Novel compounds
GB9901602D0 (en) Novel compounds
GB9901903D0 (en) Novel compounds
GB9900959D0 (en) Novel compounds
GB9901945D0 (en) Novel compounds
GB9901946D0 (en) Novel compounds
GB9901947D0 (en) Novel compounds
GB9901948D0 (en) Novel compounds
GB9902009D0 (en) Novel compounds
GB9902069D0 (en) Novel compounds
GB9900952D0 (en) Novel compounds
GB9900162D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)